Trending
News

High Cost of Care Forces Cancer Patients to Abandon Treatment – Expert

An expert has raised concerns over the rising cost of cancer treatment in Nigeria, saying the financial burden is forcing some patients to discontinue treatment and worsening outcomes.

Daniel Momodu · · 5
High Cost of Care Forces Cancer Patients to Abandon Treatment – Expert


An expert has warned that the high cost of cancer treatment in Nigeria is forcing some patients to abandon treatment, with the financial burden placing further pressure on patients and their families.

The expert said cancer care often involves prolonged treatment, including diagnosis, surgery, chemotherapy, radiotherapy and follow-up care, which can become difficult for patients to afford.

According to the expert, the high cost of medicines, diagnostic tests and other medical services has made sustained treatment challenging for many Nigerians.

The expert noted that some patients begin treatment but later discontinue it when they can no longer meet the financial demands.

The situation, the expert said, could lead to delayed treatment, disease progression and poorer health outcomes.

The expert called for stronger health insurance coverage and other interventions to reduce the financial burden of cancer care.

Stakeholders were also urged to improve access to affordable cancer services and strengthen support for patients who cannot afford treatment.

The expert said addressing the cost of care was essential to improving cancer outcomes and preventing patients from abandoning potentially life-saving treatment.

Share this story

Comments (0)

  1. Be the first to share your thoughts.

Leave a comment

All comments are moderated before publishing. Your email is never published.

Not published.

Related stories

NELFUND Boss Rejects Claims of Financial Misappropriation News

NELFUND Boss Rejects Claims of Financial Misappropriation

Managing Director of the Nigerian Education Loan Fund, Akintunde Sawyerr, has dismissed allegations of financial misappropriation within the agency, saying there is no evidence to support the claims. He also defended NELFUND’s financial processes, describing its electronic disbursement system as transparent and traceable.

Aug 31, 2026